Patents
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
12/2005
12/14/2005CN1231461C Bicyclo [2.2.1] heptanes and related compounds
12/14/2005CN1231460C Process for the preparation of (R)-or (S)-aminocarnitine inner salt, the salts and derivatives thereof
12/14/2005CN1231457C Substituted cycloheptaene and its preparation process and use
12/13/2005US6974879 Process for preparing single enantiomers of 5,5,5,5′,5′,5′-hexafluoroleucine and protected analogs
12/08/2005WO2005115971A1 Radioactive tyrosine derivative, method for producing same, labeling agent for positron imaging and medical agent for assessing grade of malignancy of tumor respectively composed of radioactive tyrosine derivative, and method for detecting tumor
12/08/2005WO2005097100A3 Antibacterial agents
12/08/2005US20050272821 Levalbuterol hydrochloride Polymorph A
12/08/2005US20050272815 Compounds and compositions for delivering active agents
12/08/2005US20050272783 Amino acids with affinity for the alpha2delta-protein
12/08/2005US20050272665 Synthesis of alpha-amino-beta-alkoxy-carboxylic acid esters
12/07/2005EP1602368A2 Cdc25 phosphatase inhibitors
12/07/2005EP1601641A2 Substituted anilide ligands for the thyroid receptor
12/07/2005CN1704404A Tricyclic protein kinase inhibitors
12/07/2005CN1230425C Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives
12/07/2005CN1230416C Pharmaceutical compounds
12/06/2005US6972300 Compounds and compositions for delivering active agents
12/06/2005US6972287 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/06/2005CA2303244C Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
12/01/2005WO2005113487A2 Polyurea compositions and compounds for the preparation thereof
12/01/2005WO2005113483A2 Levalbuterol hydrochloride polymorph a
12/01/2005WO2005113482A1 Levalbuterol hydrochloride polymorph b
12/01/2005WO2005113481A1 Preparation of levalbuterol hydrochloride
12/01/2005WO2005113471A1 Method of labeling with isotope of oxygen
12/01/2005WO2005112943A1 Topical cromolyn formulations
12/01/2005US20050267216 suspending or forming a slurry of the R enantiomer of albuterol dibenzoyl tartrate complex in at least one solvent;adding hydrogen chloride in a C1-C4 alcohol to the suspension or slurry until levalbuterol hydrochloride Polymorph B is obtained
12/01/2005US20050267208 Nordihydroguaiartic derivatives for use in treatment of tumors
12/01/2005US20050267169 Watersoluble prodrugs of propofol
12/01/2005CA2566747A1 Topical cromolyn formulations
12/01/2005CA2566605A1 Polyurea compositions and compounds for the preparation thereof
12/01/2005CA2565188A1 Compounds and compositions for delivering active agents
12/01/2005CA2556921A1 Levalbuterol hydrochloride polymorph b
12/01/2005CA2556920A1 Levalbuterol hydrochloride polymorph a
12/01/2005CA2556904A1 Preparation of levalbuterol hydrochloride
11/2005
11/30/2005CN1703394A Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents
11/30/2005CN1701814A F1K-1 is a receptor for vascular endothelial growth factor
11/30/2005CN1229344C Farnesyl transferase inhibitors
11/30/2005CN1229336C Photoactive compound used as intermediate for preparing photoactive 2-imidazoline-5-ketone or 2-imdazoline-5-thio-ketone derivative
11/30/2005CN1229332C Extraction process of 15N-L-phenylalanine
11/30/2005CN1229330C N-arylating method using amino-acid as additives
11/29/2005US6969768 Preparation of 4-haloalkylnicotinic esters
11/29/2005CA2144476C Process for preparing aminoethylglycine
11/24/2005WO2005110395A1 System and device for magnetic drug targeting with magnetic drug carrier particles
11/24/2005WO2005092011A3 Mitotic kinesin inhibitors
11/24/2005WO2005068643A3 Biochemical synthesis of 6-amino caproic acid
11/24/2005US20050261372 NMDA receptor agonist; neurodegenerative diseases, cognition activator; autism, schizophrenia, Alzheimer's disease; glycinergic and/or glutaminergic transmission activator
11/24/2005US20050261368 N-(tert-butyl)-2-methoxy-2-(4-hydroxy-3-(hydroxymethyl)phen-1-yl)-ethanamine; reduced steps for synthesis while maximizing synthetic yield without sacrificing compound purity; adding D-dibenzoyltartaric acid to mixture of racemic salbutamol in methanol; crystallizing, recrystalling in second solvent
11/24/2005US20050261318 Protein kinase inhibitors
11/24/2005US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
11/24/2005US20050261242 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents; oxidative and endothelial stress dysfunction; free radicals scavenger
11/24/2005US20050260597 Transfection reagents
11/23/2005CN1699325A A process for the preparation of 2-chloro-3-(phenylmethoxy)propionic acid potassium salt
11/23/2005CN1228312C Process for synthesizing beta-amino acid using ketone as raw material
11/22/2005CA2162122C Use of glycine-n,n-diacetic acid derivatives as biodegradable complexing agents for alkaline earth and heavy metal ions, and method of preparing them
11/17/2005WO2005108347A2 Substituted enaminones, their derivatives and uses thereof
11/17/2005WO2005108339A2 High yield and rapid syntheses methods for producing metallo-organic salts
11/17/2005US20050256199 2-Amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
11/17/2005US20050256116 Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/17/2005US20050256032 Polyoxyalkylene compound and method for making
11/17/2005US20050255138 Active agent transport systems
11/17/2005US20050253415 Vehicle and a vehicle door
11/17/2005CA2565840A1 High yield and rapid syntheses methods for producing metallo-organic salts
11/16/2005EP1594853A1 Method for the production of bicyclic aromatic amino acids and intermediate products thereof
11/16/2005EP1594843A2 Method for producing an optically active tetrahydroquinoline
11/16/2005EP1594492A2 Novel inhibitors of formation of advanced glycation endproducts (ages)
11/16/2005EP1594480A1 Method to treat chronic heart failure and/or elevated cholesterol levels
11/16/2005EP1421634B1 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
11/16/2005EP1330464B1 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation
11/15/2005US6965040 Photogenerated reagents
11/15/2005CA2379908C Preparation of metal complexes of amino acids obtained by hydrolysis of soy protein
11/10/2005WO2005105730A2 Method of preparing an alcohol from a halogenoaromatic compound and an aldehyde
11/10/2005WO2005041924A3 Administration of levodopa and carbidopa
11/10/2005US20050250857 Gelling agents
11/10/2005US20050250848 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
11/10/2005US20050250743 Ammonium salts of inositol hexaphosphate, and uses thereof
11/10/2005CA2649054A1 Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-.beta., .delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
11/09/2005EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity
11/09/2005EP1592661A2 Cyclopropyl beta-amino acid derivatives
11/09/2005EP1592657A1 Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it
11/09/2005EP1216223B1 Novel dicarboxylic acid derivatives with pharmaceutical properties
11/09/2005CN1694869A Substituted spirocyclic ketoenols
11/09/2005CN1226275C Method for preparing dextrorotary phenylalanine by asymmetric conversion method
11/09/2005CN1225972C Fungicidal compositions based on (N-phenylacetyl-N-2,6-xylyl) alaninate
11/03/2005WO2005103280A1 Process for producing optically active 4-(n-protected amino)-1-alken-3-ol and process for producing therefrom 3-benzamido-2-hydroxycarboxylic acid or salt thereof
11/03/2005WO2005102988A1 Method of separately collecting optically active amino acid amide and optically active amino acid
11/03/2005WO2005102987A1 Process for the preparation of valsartan and precursors thereof
11/03/2005WO2005102388A1 Novel blt2-mediated disease, and blt2 binding agent and compound
11/03/2005WO2005079541A3 Terephthalamide peptidomimetic compounds and methods
11/03/2005WO2005069930A3 Asymmetric hydrogenation of alpha-amino carbonyl compounds
11/03/2005US20050245762 Isolating chlorosuccinic acid by cooling to 10-20 degrees C. to effect precipitation, where the acid has been prepared by reacting a suspension of aspartic acid in demineralized water containing NaCl with NaNO2 and aqueous HCl; mother liquors from previous reactions may be used as partial substitutes
11/03/2005US20050245616 Ketoamine tumor suppressor reactivators: 3-Acetoxy-2-(acetoxymethyl)-1-oxo-1-phenylpropan-2-ammonium chloride
11/03/2005CA2563752A1 Compositions of allosteric hemoglobin modifiers and methods of making the same
11/02/2005EP1257524B1 A process for the preparation of salts of l-carnitine and alkanoyl l-carnitine with mucic acid
11/02/2005EP1157000B1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
11/02/2005EP1100443B1 Hair treatment preparation
11/01/2005US6960355 Modified amino acid compounds useful in delivery of active agents
10/2005
10/27/2005WO2005100302A1 Solid state forms of (-)-(1r,2s)-2-amino-4-methylene-cyclopentanecarboxylic acid
10/27/2005WO2005100301A1 2-aryloxyethyl glycine derivatives and their use as glycine transport inhibitors
10/27/2005WO2005100300A1 5-aminolevulinic acid salt, process for producing the same and use thereof
10/27/2005WO2005100298A1 Cetp inhibitors
10/27/2005WO2005100297A1 Indene derivatives and process for the preparation thereof